Release date: 2017-05-23
The scanning glucose monitoring system was officially launched in China on the 21st. Different from the traditional blood glucose monitoring method, this system does not need fingertips to collect blood, thus eliminating the pain and inconvenience caused. Relying on innovative technology, users only need to scan the sensor placed on the back side of the upper part of the arm to measure sugar in real time and accurately.
“The scanning glucose monitoring system has revolutionized existing blood glucose monitoring and diabetes management methods,†said Roger S. Mazze, chief academic director of the International Diabetes Center. This innovative technology will help people better control their blood sugar and further improve their daily diabetes. The convenience and effectiveness of management. Not only that, but it also provides patients and physicians with a complete map of glucose changes, providing a reliable reference for the discussion and identification of individualized treatment options. 
Ji Linong, director of the Department of Endocrinology at Peking University People's Hospital, was interviewed by the media.
It is understood that the system is equipped with a small (slightly larger than a dollar coin) circular sensor, through a small probe inserted into the skin (5 mm long, 0.4 mm wide), placed on the back side of the upper part of the arm for real-time interstitial fluid Glucose levels can be monitored for up to 14 consecutive days. When the user places the matching handheld scanning detector within 4 cm of the sensor, the scanning detector will immediately acquire the current glucose data. The test is painless throughout the procedure and does not require blood sampling at the fingertips for calibration.
In addition, after each scan, the scan detector not only displays the current glucose readings in real time, but also displays the glucose pattern for the last 8 hours and a trend arrow indicating glucose changes. The detector can store up to 90 days of glucose data. Systematic data derived from computer software can be used to review its dynamic glucose profile to understand the effects of diet, exercise, and insulin on glucose fluctuations.
Ji Linong, director of the Department of Endocrinology at Peking University People's Hospital, pointed out that blood glucose monitoring is a key part of diabetes management. It reduces the risk of developing serious complications such as heart disease, kidney failure and diabetic foot. The more times you measure blood sugar every day, the better people can understand the individual's glucose levels. This can help them manage diabetes more accurately, reduce the risk of complications, and improve health.
Ji Linong pointed out that this new technology not only provides a more convenient and painless blood glucose monitoring method for diabetic patients, but also allows them to obtain more accurate blood glucose data. The trend and regularity of glucose provided by the system are also of guiding significance. This information can help diabetics and doctors make decisions about how to adjust their diet and other behaviors when communicating, so they can better manage their disease. It meets the most important needs of patients.
Source: China News Network
Intermediate for Cas 877399-52-5
Crizotinib Intermediate,Crizotinib Api,Crizotinib Cas 877397-65-4,Crizotinib Intermediates
Shandong Bolode Bio-technology Co., Ltd. , https://www.bldpharma.com